Literature DB >> 20920140

Predicting early mortality in acute exacerbation of chronic obstructive pulmonary disease using the CURB65 score.

Catherina L Chang1, Glenda D Sullivan, Noel C Karalus, Graham D Mills, John D McLachlan, Robert J Hancox.   

Abstract

BACKGROUND AND
OBJECTIVE: Hospitalization for exacerbation of COPD is associated with a high risk of mortality. A risk-prediction model using information easily obtained on admission could help to identify high-risk individuals. The CURB65 score was developed to predict mortality risk in community acquired pneumonia. A retrospective study found that this score was also associated with mortality in COPD exacerbations. We conducted a prospective study to assess the utility of the CURB65 score in acute COPD exacerbations.
METHODS: Consecutive patients with physician diagnosed COPD exacerbations admitted to a public hospital during a 1-year period were studied prospectively. The CURB65 scores were calculated from information obtained at initial hospital presentation. CURB65 = one point each for Confusion, Urea > 7 mmol/L, Respiratory rate ≥ 30/min, low Blood pressure, age ≥ 65 years.
RESULTS: 30-day mortality data were available for 249 of 252 patients. CURB65 scores on admission significantly predicted risk of death during the hospital admission and at 30 days. The 30-day mortality by score groups were: low risk (scores 0-1) 2.0% (2/98), moderate risk (score 2) 6.7% (6/90) and high risk (scores 3-5) 21.3% (13/61). CURB65 scores were not predictive of 1-year mortality.
CONCLUSIONS: A simple 6-point score based on confusion, blood urea, respiratory rate, blood pressure and age can be used to stratify patients with COPD exacerbation into different management groups. The CURB65 score was as effective in predicting early mortality in our cohort of acute COPD exacerbations as it was in previous cohorts with community acquired pneumonia. Our findings suggest that CURB65 scores can help clinicians to assess patients with exacerbation of COPD.
© 2010 The Authors. Respirology © 2010 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20920140     DOI: 10.1111/j.1440-1843.2010.01866.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  19 in total

1.  Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department.

Authors:  Ian G Stiell; Jeffrey J Perry; Catherine M Clement; Robert J Brison; Brian H Rowe; Shawn D Aaron; Andrew D McRae; Bjug Borgundvaag; Lisa A Calder; Alan J Forster; Jennifer Brinkhurst; George A Wells
Journal:  CMAJ       Date:  2018-12-03       Impact factor: 8.262

2.  Letters to the editor.

Authors: 
Journal:  Ochsner J       Date:  2013

3.  Acute COPD exacerbation presenting with pronounced intrabullous haemorrhage and haemoptysis.

Authors:  Daniel Runggaldier; Taro Minami; Daniel Golding; Kamran Manzoor
Journal:  BMJ Case Rep       Date:  2018-06-28

4.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

5.  Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study.

Authors:  Ian G Stiell; Catherine M Clement; Shawn D Aaron; Brian H Rowe; Jeffrey J Perry; Robert J Brison; Lisa A Calder; Eddy Lang; Bjug Borgundvaag; Alan J Forster; George A Wells
Journal:  CMAJ       Date:  2014-02-18       Impact factor: 8.262

6.  Preferences for Predictive Model Characteristics among People Living with Chronic Lung Disease: A Discrete Choice Experiment.

Authors:  Gary E Weissman; Kuldeep N Yadav; Trishya Srinivasan; Stephanie Szymanski; Florylene Capulong; Vanessa Madden; Katherine R Courtright; Joanna L Hart; David A Asch; Sarah J Ratcliffe; Marilyn M Schapira; Scott D Halpern
Journal:  Med Decis Making       Date:  2020-06-12       Impact factor: 2.583

7.  Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm.

Authors:  Werner C Albrich; Frank Dusemund; Kristina Rüegger; Mirjam Christ-Crain; Werner Zimmerli; Thomas Bregenzer; Sarosh Irani; Ulrich Buergi; Barbara Reutlinger; Beat Mueller; Philipp Schuetz
Journal:  BMC Infect Dis       Date:  2011-05-03       Impact factor: 3.090

8.  The Pneumonia Severity Index as a Predictor of In-Hospital Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Guoping Hu; Yumin Zhou; Yankui Wu; Yan Yu; Weiqiang Liang; Pixin Ran
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

9.  Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Dong Liu; Shao-Hua Peng; Jing Zhang; Si-Hong Bai; Hai-Xia Liu; Jie-Ming Qu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-02

10.  Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial.

Authors:  Werner C Albrich; Kristina Rüegger; Frank Dusemund; Philipp Schuetz; Birsen Arici; Alexander Litke; Claudine A Blum; Rita Bossart; Katharina Regez; Ursula Schild; Merih Guglielmetti; Antoinette Conca; Petra Schäfer; Maria Schubert; Sabina de Geest; Barbara Reutlinger; Sarosh Irani; Ulrich Bürgi; Andreas Huber; Beat Müller
Journal:  Eur Respir J       Date:  2013-01-24       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.